The TRMT13 siRNA and TRMT13+/+ groups presented larger and smaller mean tumor masses, respectively, than the control group (Figure 5D).Figure 5E showed the inhibitory effects ofTRMT13 on PTC progressionin vivo. Here, TRMT13 is linked to neoplasm.